CorVel Corporation — Form 10-K Summary
Reporting period: Fiscal year ended March 31, 2013, with comparisons to fiscal 2012 and 2011. The request metadata says “2011 Q4,” but the supplied filing is CorVel’s fiscal 2013 annual report; it also provides unaudited quarterly results. Amounts below are in U.S. dollars.
Business context
CorVel provides workers’ compensation and other healthcare claims cost-containment services to insurers, third-party administrators (TPAs), employers, and government entities. Its offerings include claims administration, medical bill review, provider networks, case management, utilization review, pharmacy, and directed-care services. It reports one operating segment: managed care.
Financial performance and liquidity
| Metric | FY2013 | FY2012 | Change |
|---|---|---|---|
| Revenue | $429.3 million | $412.7 million | +4.0% |
| Gross profit | $91.7 million | $93.8 million | −2.3% |
| Gross margin | 21.4% | 22.7% | −1.3 percentage points |
| Income before taxes | $43.9 million | $43.4 million | +1.1% |
| Net income | $26.7 million | $26.6 million | +0.7% |
| Diluted earnings per share | $2.38 | $2.28 | +4.4% |
- Cost of revenue rose 5.9% to $337.7 million, faster than sales. Management attributed margin pressure to higher-margin business lost and replaced by lower-margin work. Pharmacy costs increased from $43 million to $51 million; direct labor costs rose from $84 million to $92 million.
- General and administrative expense fell 5.2% to $47.8 million, principally due to lower compensation costs and reduced stock compensation. The effective tax rate was approximately 39% in both FY2013 and FY2012.
- Patient management revenue increased 11.4% to $222 million, while network solutions revenue declined 2.8% to $208 million. Patient management rose to 51.5% of revenue from 49.3%, primarily reflecting TPA growth; network solutions fell to 48.5%.
- Cash from operations was $54.8 million, up from $35.7 million. Investing cash outflow was $14.9 million, mainly property and equipment purchases; financing cash outflow was $26.7 million, largely share repurchases. Cash and cash equivalents ended the year at $19.8 million, versus $6.6 million a year earlier.
- Current assets were $92.9 million and current liabilities $52.8 million, for working capital of approximately $40.1 million. The company had no debt outstanding. Its revolving facility provided up to $10 million and was scheduled to expire in September 2013; $8 million of letters of credit were outstanding under a separate sub-limit.
- Days sales outstanding improved from 43 to 40 days. Total assets were $182.4 million and stockholders’ equity $111.4 million at March 31, 2013.
Material changes and notable items
- Revenue growth slowed from 8.4% in FY2012 to 4.0% in FY2013, while gross profit declined for a second consecutive year. Management said margins would need higher-margin sales or operating efficiencies to improve and that the direction of gross profit was uncertain.
- FY2013 fourth-quarter revenue was $112.0 million, gross profit $23.9 million, net income $7.6 million, and diluted EPS $0.70. In the year-earlier quarter, the respective figures were $104.4 million, $21.5 million, $5.1 million, and $0.44.
- CorVel repurchased 705,406 shares for $30.7 million in FY2013. Cumulative repurchases under the program reached 15.7 million shares for approximately $301 million; 341,433 shares remained authorized at fiscal year-end. The company paid no cash dividend and reported no current plan to do so.
- The company recorded no FY2013 impairment of goodwill or other long-lived assets. Prior FY2011 results included a $9 million legal-settlement accrual; there was no comparable accrual in FY2012 or FY2013.
Outlook, risks, and contingencies
- Management expected TPA services to offer more growth opportunity than other service lines and expected DSO to remain around 40 days. It believed cash, operating cash flow, and the credit facility would cover expected needs for at least 12 months. The filing provides no specific revenue, earnings, or margin guidance.
- Management identified pricing pressure and business mix as threats to profitability, while noting operating efficiencies could support improvement. It also cited fewer workers’ compensation claims and patient referrals, customer insourcing, competition, and contract renewals as risks to growth.
- Other material risks include regulatory changes, litigation and professional-liability exposure, data security or service interruptions, dependence on technology and key personnel, and rising labor and benefit costs. The company said healthcare reform was not expected to materially affect revenue but could raise employee healthcare costs.
- CorVel was involved in ordinary-course litigation; management did not expect aggregate resolution payments to be material. The company also disclosed $47.8 million in future minimum operating lease payments and $3.5 million in software-license commitments. Certain indemnification obligations were not quantified, and no liability was recorded for them.
- After year-end, CorVel repurchased 92,658 additional shares for $4.5 million and announced a two-for-one stock split, to be distributed in June 2013. A three-year desktop software-license agreement totaling $3.5 million began April 1, 2013.
Most important facts for investors to verify
- Whether TPA-driven growth can offset declining case-management referrals and network-solutions revenue.
- Whether gross-margin compression persists, and whether management can restore margins through pricing, service mix, or efficiencies.
- Renewal or replacement of the revolving credit facility scheduled to expire in September 2013, and the status of its covenants and letters of credit.
- Cash generation after substantial repurchases, remaining repurchase authorization, and subsequent share-count effects, including the stock split.
- Developments in litigation, regulatory requirements, customer retention, and the company’s ability to protect and maintain its claims-processing systems.